Skip to content

Clinical trials

Phase 1 Cardiomyopathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 1 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20141
20151
20163
20191
20202
20223
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Terminated1
Unknown status1
Withdrawn1
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
University of Michigan2
Yale University2
Abramson Cancer Center at Penn Medicine1
Adjuvia Therapeutics, Inc.1
Capricor Inc.1
Emory University1
Losordo, Douglas, M.D.1
Pfizer1
RegeneRx Biopharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies18
Heart Failure12
Cardiovascular Diseases3
Breast Neoplasms2
Cardiomyopathy, Dilated2
Friedreich Ataxia2
Heart Diseases2
Myocardial Infarction2
Myocardial Ischemia2
Ataxia1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.